Gene therapy for human osteoarthritis: principles and clinical translation

Area of Science:

• Orthopedics and Regenerative Medicine
• Gene Therapy Applications
• Biotechnology in Musculoskeletal Health

Background:

• Osteoarthritis (OA) is a prevalent chronic joint disease characterized by progressive articular cartilage loss.
• Gene therapy aims to deliver gene-based agents to osteoarthritic cartilage for localized, long-term cartilage rebuilding.
• Understanding gene transfer principles is crucial for developing effective OA treatments.

Purpose of the Study:

• To provide an overview of gene therapy principles for osteoarthritis.
• To review gene transfer methods in cartilage, both in vitro and in vivo.
• To discuss and contextualize results from recent clinical gene therapy trials for OA.

Main Methods:

• Literature search of PubMed for gene therapy in osteoarthritis.
• Review of in vitro and in vivo studies on gene transfer to normal and osteoarthritic cartilage.
• Analysis of outcomes from clinical trials involving gene therapy for OA.

Main Results:

• Recombinant adeno-associated viral (rAAV) vectors can transfer sequences to human chondrocytes for cartilage modulation.
• Few preclinical animal studies specifically in OA models have been conducted.
• Clinical trials using intraarticular injection of chondrocytes overexpressing TGF-β1 via retroviral vectors have shown promise.

Conclusions:

• Gene therapy, particularly with rAAV vectors, is a potent tool for modulating osteoarthritic cartilage structure.
• Clinical trials involving gene therapy for end-stage knee OA have demonstrated improved clinical scores compared to placebo.
• Translational results warrant continued clinical testing of gene transfer protocols for OA treatment.